We discussed the emerging data of the importance of asparaginase in the 
treatment of ALL. We discussed the potential toxicities and how we can 
manage them. The time point of application plays after cheotherpay is of 
major importance. Monitoring for pancreatitis and bleeding should be 
done routinely.

Presenter: Prof. Spyridondis
Participants: Dr Liga, Dr Spyridis, Dr Aggelinas